Zhao WL - Search Results

1

Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trial.

Zhang MC, Tian S, Fu D, Wang L, Cheng S, Yi HM, Jiang XF, Song Q, Zhao Y, He Y, Li JF, Mu RJ, Fang H, Yu H, Xiong H, Li B, Chen SJ, Xu PP, Zhao WL. Zhang MC, et al. Among authors: zhao y, zhao wl. Cancer Cell. 2023 Oct 9;41(10):1705-1716.e5. doi: 10.1016/j.ccell.2023.09.004. Epub 2023 Sep 28. Cancer Cell. 2023. PMID: 37774697 Free article.

2

Retinoic acid and arsenic for treating acute promyelocytic leukemia.

Zhou GB, Zhao WL, Wang ZY, Chen SJ, Chen Z. Zhou GB, et al. Among authors: zhao wl. PLoS Med. 2005 Jan;2(1):e12. doi: 10.1371/journal.pmed.0020012. PLoS Med. 2005. PMID: 15696202 Free PMC article. Review.

3

NOTCH1 mutations in T-cell acute lymphoblastic leukemia: prognostic significance and implication in multifactorial leukemogenesis.

Zhu YM, Zhao WL, Fu JF, Shi JY, Pan Q, Hu J, Gao XD, Chen B, Li JM, Xiong SM, Gu LJ, Tang JY, Liang H, Jiang H, Xue YQ, Shen ZX, Chen Z, Chen SJ. Zhu YM, et al. Among authors: zhao wl. Clin Cancer Res. 2006 May 15;12(10):3043-9. doi: 10.1158/1078-0432.CCR-05-2832. Clin Cancer Res. 2006. PMID: 16707600

4

[BCL-XL expression and mutation in non-Hodgkin's lymphoma].

Liu YH, Leboeuf C, Jin XL, Xiao JC, Janin A, Chen SJ, Zhao WL. Liu YH, et al. Among authors: zhao wl. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Oct;14(5):903-7. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006. PMID: 17096886 Chinese.

5

Rituximab plus CHOP (R-CHOP) overcomes PRDM1-associated resistance to chemotherapy in patients with diffuse large B-cell lymphoma.

Liu YY, Leboeuf C, Shi JY, Li JM, Wang L, Shen Y, Garcia JF, Shen ZX, Chen Z, Janin A, Chen SJ, Zhao WL. Liu YY, et al. Among authors: zhao wl. Blood. 2007 Jul 1;110(1):339-44. doi: 10.1182/blood-2006-09-049189. Epub 2007 Mar 22. Blood. 2007. PMID: 17379744 Free article.

6

Combined effects of histone deacetylase inhibitor and rituximab on non-Hodgkin's B-lymphoma cells apoptosis.

Zhao WL, Wang L, Liu YH, Yan JS, Leboeuf C, Liu YY, Wu WL, Janin A, Chen Z, Chen SJ. Zhao WL, et al. Exp Hematol. 2007 Dec;35(12):1801-11. doi: 10.1016/j.exphem.2007.06.009. Epub 2007 Aug 3. Exp Hematol. 2007. PMID: 17681667 Free article.

7

[Expression of tumor suppressor gene PRDM1 in lung cancers].

Liu YY, Yang SJ, Ma J, Wang L, Liu YH, Chen SJ, Shen ZX, Zhao WL. Liu YY, et al. Among authors: zhao wl. Zhonghua Zhong Liu Za Zhi. 2007 Jun;29(6):434-6. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 17974277 Chinese.

8

PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitor.

Zhao WL, Liu YY, Zhang QL, Wang L, Leboeuf C, Zhang YW, Ma J, Garcia JF, Song YP, Li JM, Shen ZX, Chen Z, Janin A, Chen SJ. Zhao WL, et al. Blood. 2008 Apr 1;111(7):3867-71. doi: 10.1182/blood-2007-08-108654. Epub 2008 Jan 30. Blood. 2008. PMID: 18235046 Free article.

9

[Analysis of overexpression of vascular endothelial growth factor-C in patients with angioimmunoblastic T-cell lymphoma].

Zhao WL, Liu YY, Plassa F, Jin XL, Wang L, Janin A, Shen ZX. Zhao WL, et al. Zhonghua Xue Ye Xue Za Zhi. 2007 Oct;28(10):664-6. Zhonghua Xue Ye Xue Za Zhi. 2007. PMID: 18399170 Chinese.

10

FIP1L1-PDGFRalpha alone or with other genetic abnormalities reveals disease progression in chronic eosinophilic leukemia but good response to imatinib.

Wang LN, Pan Q, Fu JF, Shi JY, Jin J, Li JM, Hu J, Zhao WL, Chen Z, Chen SJ. Wang LN, et al. Among authors: zhao wl. Chin Med J (Engl). 2008 May 20;121(10):867-73. Chin Med J (Engl). 2008. PMID: 18706197

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

379 results

Search Page